StockData

NextCure, Inc. (NXTC) income statement

NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$6.45−0.33 (-4.87%)

Close on Nov 20, 2026Market cap $29.52MP/E –Yield 0.00%

See a number that looks wrong?